SARS-CoV-2 seroprevalence survey estimates are affected by anti-nucleocapsid antibody decline

We analyzed 21,676 residual specimens from Ontario, Canada collected between March-August, 2020 to investigate the effect of antibody decline on SARS-CoV-2 seroprevalence estimates. Testing specimens orthogonally using the Abbott (anti-nucleocapsid) and then the Ortho (anti-spike) assays, seropreval...

Descripción completa

Detalles Bibliográficos
Autores principales: Bolotin, Shelly, Tran, Vanessa, Osman, Selma, Brown, Kevin A, Buchan, Sarah A, Joh, Eugene, Deeks, Shelley L, Allen, Vanessa G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7928877/
https://www.ncbi.nlm.nih.gov/pubmed/33400794
http://dx.doi.org/10.1093/infdis/jiaa796

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7928877/
https://www.ncbi.nlm.nih.gov/pubmed/33400794
http://dx.doi.org/10.1093/infdis/jiaa796

Ejemplares similares